1-231040151-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198552.3(FAM89A):c.61G>A(p.Val21Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000115 in 1,302,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198552.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM89A | NM_198552.3 | c.61G>A | p.Val21Met | missense_variant | 1/2 | ENST00000366654.5 | NP_940954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM89A | ENST00000366654.5 | c.61G>A | p.Val21Met | missense_variant | 1/2 | 1 | NM_198552.3 | ENSP00000355614.4 |
Frequencies
GnomAD3 genomes AF: 0.00000671 AC: 1AN: 149112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000187 AC: 1AN: 53366Hom.: 0 AF XY: 0.0000318 AC XY: 1AN XY: 31470
GnomAD4 exome AF: 0.0000121 AC: 14AN: 1153448Hom.: 0 Cov.: 31 AF XY: 0.0000107 AC XY: 6AN XY: 561190
GnomAD4 genome AF: 0.00000671 AC: 1AN: 149112Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 72668
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2024 | The c.61G>A (p.V21M) alteration is located in exon 1 (coding exon 1) of the FAM89A gene. This alteration results from a G to A substitution at nucleotide position 61, causing the valine (V) at amino acid position 21 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at